期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
生脉超微颗粒与其散剂中五味子醇甲药代动力学的对比研究 被引量:3
1
作者 李跃辉 杨永华 +1 位作者 刘璇 蔡光先 《中华中医药杂志》 CAS CSCD 北大核心 2005年第10期588-590,共3页
目的:测定生脉超微颗粒与其散剂中五味子醇甲的体内药代动力学参数,为生脉超微颗粒代替其传统散剂提供实验依据。方法:采用HPLC法。DAS 1.0药代动力学软件拟合药动学模型。结果:大鼠灌胃给予生脉超微颗粒与其散剂后五味子醇甲的体内过... 目的:测定生脉超微颗粒与其散剂中五味子醇甲的体内药代动力学参数,为生脉超微颗粒代替其传统散剂提供实验依据。方法:采用HPLC法。DAS 1.0药代动力学软件拟合药动学模型。结果:大鼠灌胃给予生脉超微颗粒与其散剂后五味子醇甲的体内过程均符合一房室模型,药动参数为Cmax分别为1.241、1.053μg/m l;Tmax分别为0.750、1.000h;AUC 0-6分别为2.210、2.615(mg.L-1.h-1);t1/2α分别为0.872、1.109h。结论:生脉散经超微粉化后,五味子醇甲体内的吸收加快,生物利用度提高。 展开更多
关键词 超微颗粒 生脉散剂 五味子醇甲 药代动力学 物利用度 中医药疗法
下载PDF
Study on the Protective Effect of Shengmai San(生脉散) on the Myocardium in the Type 2 Diabetic Cardiomyopathy Model Rat 被引量:5
2
作者 倪青 王阶 +4 位作者 李恩庆 赵安斌 于斌 王敏 黄春荣 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2011年第3期209-219,共11页
Objective:To study the effect of Shengmai San(生脉散Pulse-activating Powder) in protecting myocardium in the rat of the type 2 diabetic cardiomyopathy(DCM) model.Methods:The DCM rat model was established by combinatio... Objective:To study the effect of Shengmai San(生脉散Pulse-activating Powder) in protecting myocardium in the rat of the type 2 diabetic cardiomyopathy(DCM) model.Methods:The DCM rat model was established by combination of insulin resistance induced by a high-fat diet with intraperitoneal injection of high dose streptozotocin(50 mg/kg).And these rat models were randomly divided into three groups:a normal group(n=12,one of them died),a model group(n=15) and a Shengmai San group(treatment group,n=15).The damage of the myocardium was assessed by electrocardiogram at the twelfth week after modeling,and the blood glucose,cholesterol and triglyceride levels were determined;the content of the left cardiac ventricle myocardial collagen was quantified by Masson staining test;the level of myocardial cell apoptosis was detected with TUNEL apoptosis detection kit;the damage extent of the myocardial sub-cellular structures was observed by electron microscopy;the expression levels of cardiac TSP-1(Thrombospondin-1),TGF-β1(Transforming Growth Ffactor-β) and TRB-3(Tribbles homolog 3) proteins were detected by immunohistochemical method;the expression levels of cardiac TSP-1,A-TGF-β1 and L-TGF-β1 proteins were detected by Western blotting;and the expression levels of TSP-1 and TRB-3 mRNAs were detected by real-time quantitative PCR.Results:Compared with the control group,the blood glucose,cholesterol,triglycerides levels in both the model groups and the Shengmai San group were significantly decreased;the myocardial tissue was less damaged and the collagen content was reduced in the Shengmai San group;the myocardial sub-cellular structure was injured to a lesser extent;the expression levels of myocardial TSP-1,TGF-β1,TRB-3,and TSP-1,A-TGF-β1,L-TGF-β1 and chymase were decreased,and the expression levels of TSP-1 mRNA and TRB-3 mRNA were decreased in both the model groups and the Shengmai San group(the latter was better),.Conclusion:Shengmai San can inhibit myocardial fibrosis in the rat of diabetic cardiomyopathy,and significantly delay the formation of diabetic cardiomyopathy in hyperglycemia rats through multiple pathways. 展开更多
关键词 Shengmai San diabetic cardiomyopathy collagen fiber apoptosis TSP-1 TGF-β1 TRB-3 CHYMASE
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部